Lv75
3220 积分 2023-01-06 加入
Radiation-Activated Resiquimod Prodrug Nanomaterials for Enhancing Immune Checkpoint Inhibitor Therapy
6天前
已完结
Extensive and differential platinum chemotherapy mutagenesis in livers of children
1个月前
已完结
Weight Loss without Food Intake Suppression through Size-Dependent Retention of Anti-Inflammatory Nanomedicines
1个月前
已完结
Synergistic mechanism of olaparib and cisplatin on breast cancer elucidated by network pharmacology
1个月前
已完结
Cisplatin in the era of PARP inhibitors and immunotherapy
1个月前
已完结
Emerging Therapeutic Strategies in Prostate Cancer: Targeted Approaches Using PARP Inhibition, PSMA-Directed Therapy, and Androgen Receptor Blockade with Olaparib, Lutetium (177Lu)Vipivotide Tetraxetan, and Abiraterone
1个月前
已完结
Design, synthesis and biological evaluation of novel PARP inhibitors against acquired drug-resistance
1个月前
已完结
YCH1899, a Highly Effective Phthalazin-1(2H)-one Derivative That Overcomes Resistance to Prior PARP Inhibitors
1个月前
已完结
PARP inhibition generates enhanced CD8+ central memory T cells by transcriptional and metabolic reprogramming
1个月前
已完结
Clinical application of PARP inhibitors and emerging strategies to overcome resistance: a pan-cancer perspective
2个月前
已关闭
皖公网安备34019202002308
